Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial

The reporting of adverse drug reactions (ADR) by patients represents an interesting challenge in the field of pharmacovigilance, but the reporting system is not adequately implemented in France. In 2015, only ...

Source: Trials - March 9, 2018 Category: General Medicine Authors: Gilles Defer, Florian Le Caignec, Sophie Fedrizzi, Fran çois Montastruc, Damien Chevanne, Jean-Jacques Parienti and Laure Peyro-Saint-Paul Tags: Study protocol Source Type: research